Figure 4.
Effect of megakaryocyte depletion on osteoblast thickening. (A) Flow cytometric analysis of peripheral blood at days 0, 3, and 6 of DT injections showing depletion of peripheral platelets (top) and flow cytometric analysis of BM from PF4/iDTR mouse after 5-day treatment with DT and 48 hours after irradiation showing depletion of CD41+ cells (below). (B) Mean platelet counts decreased by 85% compared with DT-treated controls. (C) IF-stained sections (20× top; 40× middle) of BM metaphysis showing significant CD41 (red) depletion and thickening of GFP (green)-labeled osteoblasts in PF4/iDTR × Col2.3GFP triple transgenic mice and PF4Cre– controls treated with DT and 48 hours after irradiation. H&E-stained sections (40× bottom) of PF4/iDTR and PF4Cre– control mice demonstrating similar osteoblast thickening. (D) Analysis of osteoblast thickness in PF4Cre DT depletion compared with PF4Cre– controls shows increased osteoblast thickness compared with irradiated controls (cell thickness, 7.51 ± 0.62 μm vs 7.16 ± 0.43 μm; P = ns). RBC, red blood cell.